Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways
2011 · Hepatology · 65 citations
https://doi.org/10.1002/hep.25549
W
Wengang Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
260
Papers
5.3K
Citations
36
h-index
92
i10-index
Wengang Li is an academic researcher. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 36, co-authored 221 publications.
ORCID: 0000-0002-6980-1776Papers by this author
worksHistone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression
2020 · Journal of Biological Chemistry · 35 citations
https://doi.org/10.1074/jbc.ra120.015335
Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling
2015 · Journal of Biological Chemistry · 34 citations
https://doi.org/10.1074/jbc.m115.640490
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
2024 · Hepatology International · 29 citations
https://doi.org/10.1007/s12072-024-10702-5
Dynamic ginsenoside-sheltered nanocatalysts for safe ferroptosis-apoptosis combined therapy
2022 · Acta Biomaterialia · 28 citations
https://doi.org/10.1016/j.actbio.2022.08.026
Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study
2023 · Radiation Oncology · 21 citations
https://doi.org/10.1186/s13014-023-02270-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat